Impact of TA-SUA Levels on Mortality in Peritoneal Dialysis

Overview of Time-Averaged Serum Uric Acid (TA-SUA)

Time-Averaged Serum Uric Acid (TA-SUA) refers to the average serum uric acid levels measured over a specific period, providing a more stable indicator of uric acid levels than a single snapshot measurement. This concept is particularly pertinent in chronic conditions, such as kidney disease, where fluctuations in serum uric acid can significantly affect patient outcomes. Notably, TA-SUA serves as an important marker for evaluating the risk of cardiovascular morbidity and mortality in various populations, especially those on dialysis. TA-SUA’s role in chronic kidney disease (CKD) patients has been a subject of increased focus, particularly in understanding its association with mortality rates in patients undergoing peritoneal dialysis (PD).

Recent studies have indicated that lower TA-SUA levels may correlate with a higher risk of mortality in patients with CKD. For instance, research shows that TA-SUA levels lower than 5.1 mg/dL are linked with increased cardiovascular and all-cause mortality rates in dialysis patients (Tarricone et al., 2025). This highlights the importance of monitoring TA-SUA levels in clinical settings, as they may provide insights into patient nutritional status and overall health.

Relationship Between TA-SUA Levels and Mortality in Dialysis Patients

The relationship between TA-SUA levels and mortality in dialysis patients is complex. Patients with lower TA-SUA levels often present with multiple comorbidities, including malnutrition and increased inflammation, which contribute to higher mortality risks. In a study by Tarricone et al. (2025), it was found that presenting eGFR (estimated Glomerular Filtration Rate) significantly influenced clinical outcomes in patients with diabetic foot infections, with lower eGFR levels correlating with higher mortality rates.

Interestingly, the study indicated that while TA-SUA levels did not affect the rates of wound healing or time to heal, they were associated with increased mortality and the likelihood of rehospitalization for infections. The findings suggest that lower TA-SUA levels might serve as a potential risk factor for mortality in patients undergoing dialysis, reinforcing the need for regular monitoring and management of uric acid levels.

Table 1: Mortality Rates Based on TA-SUA Levels

Influence of eGFR on Diabetic Foot Infection Outcomes

The eGFR is a crucial indicator of kidney function and has a profound impact on various health outcomes, particularly in patients with diabetic foot infections. Lower eGFR levels are associated with more severe complications, including higher rates of re-infection and mortality. In the aforementioned study, patients with eGFR <30 mL/min displayed significantly elevated mortality rates compared to those with higher eGFR values, emphasizing the critical role of kidney function in managing diabetic foot complications (Tarricone et al., 2025).

Table 2: Clinical Outcomes Based on eGFR Levels

These statistics underscore the necessity of recognizing and addressing the challenges faced by patients with diminished kidney function, particularly in the context of diabetic foot infections.

Key Risk Factors for Mortality in Patients with Diabetic Foot Infections

Several risk factors have been identified that contribute to increased mortality rates in patients with diabetic foot infections. These include:

• Chronic Kidney Disease: Patients with lower eGFR levels are at a significantly higher risk of mortality and complications related to diabetic foot infections (Tarricone et al., 2025).
• Peripheral Arterial Disease: This condition is more prevalent in patients with lower eGFR levels and is associated with higher rates of amputation and infections.
• Malnutrition: Low TA-SUA levels often reflect malnutrition, which can exacerbate complications in diabetic patients.
• Comorbid Conditions: Conditions such as retinopathy and diabetes-related complications also heighten the risk of adverse outcomes.

Table 3: Risk Factors for Mortality in Diabetic Foot Infection Patients

Implications for Clinical Management and Future Research

The findings regarding TA-SUA levels and their association with mortality in dialysis patients highlight the necessity for improved clinical management strategies. Regular monitoring of TA-SUA and eGFR levels should be integrated into routine care for patients undergoing dialysis, particularly those with diabetic foot infections. Additionally, addressing nutritional deficits and managing comorbid conditions are essential components of patient care that can potentially improve outcomes.

Future research should focus on establishing whether interventions aimed at normalizing TA-SUA levels can reduce mortality in dialysis patients. Investigations into the mechanisms by which TA-SUA influences mortality, despite its association with malnutrition, will also be crucial in developing targeted interventions.

FAQ Section

What is TA-SUA?

TA-SUA stands for Time-Averaged Serum Uric Acid, which measures average uric acid levels over a specified period, providing insights into a patient’s long-term health status.

How does TA-SUA relate to mortality in dialysis patients?

Studies have shown that lower TA-SUA levels are linked to higher mortality rates in dialysis patients, indicating its potential role as a risk factor.

What impact does eGFR have on diabetic foot infections?

Lower eGFR levels are associated with increased mortality and complications in patients with diabetic foot infections, highlighting the importance of kidney function in patient outcomes.

What are the key risk factors for mortality in diabetic foot infections?

Key risk factors include chronic kidney disease, peripheral arterial disease, malnutrition, and comorbid conditions.

How should clinicians manage patients with low TA-SUA levels?

Clinicians should regularly monitor TA-SUA and eGFR levels, address nutritional needs, and manage comorbid conditions to improve patient outcomes.

References

1. Tarricone, A., Coye, T. L., Gee, A., Najafi, B., Siah, M. C., & Lavery, L. A. (2025). The dialysis foot‐ the impact of presenting estimated glomerular filtration rate on clinical outcomes in patients hospitalized with diabetic foot infections. International Wound Journal

2. Jabeen, S., Hasan, M., Acharya, S., Rahman, M. M., Rafii-Tabar, E., Hall, S., Dewan, F., Alim, A., Akhter, S., Chowdhury, S. R., Mahmud, M., Prodhan, M. J. A., Rouf, S., Chowdhury, S., Nasreen, S. K. Z., Hossain, F., Begum, F., Chandrima, R. M., Al-Zubayer, M. A., Sarwar, G., Khan, M., Akhter, F., Rubayet, S., Ahmed, A., & El Arifeen, S. (2025). Improving the provision for gynaecological health care in Bangladesh using Essential Gynaecological Skills implementation package: a stakeholder-driven approach in public health facilities. Journal of Global Health

3. Ozdemir, E., Zhuoni, X., Griffiths, H., & Macbeth, A. (2025). Alexithymia in Schizophrenia and Psychosis Vulnerability: A Systematic Review and Meta‐Analysis. Journal of Clinical Psychology

4. Nwankwo, H., Mason, J., Underwood, M., Parsons, H., Haque, A., Torgerson, D., & Kearney, R. S. (2025). Cost utility analysis of acute rehabilitation approaches in the management of traumatic anterior shoulder dislocation. Bone & Joint Open. https://doi.org/10.1302/2633-1462.65.BJO-2024-0246.R1

5. Bowman, J., Zhou, C., Zasadzinski, L., Zhu, M., & Saunders, M. R. (2025). CKD Knowledge and CKD Report Card Use During a Nephrology Encounter: A Randomized Trial. Kidney Medicine. https://doi.org/10.1016/j.xkme.2025.100991